Biotechnology company Athos Therapeutics announced on September 21, 2025, the launch of "Athos Omics AI," a commercial no-code platform for analyzing multi-omics data (genomics, proteomics, etc.). This tool aims to solve one of the main problems in R&D: biologists and chemists often lack the programming skills to analyze complex datasets. The platform offers an intuitive graphical interface that allows researchers to simply "drag and drop" their data files and run complex analytical pipelines without writing a single line of code. AI agent-based systems automatically perform data preprocessing, integration, and visualization, quickly generating reports. This approach is designed to radically accelerate R&D in the pharmaceutical, food, and cosmetics industries by enabling domain experts to work directly with data and gain valuable insights.
Athos Therapeutics Launches "Athos Omics AI" No-Code Platform for Bio-data Analysis
